Alain D. Cappeluti

Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD.

OTraces, Inc. provides transformative oncology diagnostic systems and services to detect cancer. It has developed a protein-based method (proteomics) for detecting cancers with simple blood tests. It offers CDx instrument system, OTraces reagenat test kits, BC sera Dx test kit, PR sera Dx test kit, and Pipeline. The company was founded by Keith Lingerfelter and Alain Cappeluti in 2008 and is headquartered in Sykesville, MD.

CavitroniX Corp. manufactures custom design and development of emulsion chambers for boilers, turbines and engines. It specializes in engineering, design, development, manufacturing and sale of water-in-fuel emulsification units. The company was founded by Charle P. Lickson, Charles Markert and Michael Noble in 2006 and is headquartered in Bristol, VA.

Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD.

BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.